Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Montelukast as an Alternative or Supplementary Treatment in ENL Reaction in Leprosy

NCT00406861 is registered in ClinicalTrials.gov with The Leprosy Mission Bangladesh as lead sponsor.

NCT NCT00406861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00406861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Montelukast as an Alternative or Supplementary Treatment in ENL Reaction in Leprosy
Lead sponsor
The Leprosy Mission Bangladesh
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2006
Completion date
June 30, 2009
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythema nodosum leprosum, leprosy